Topic Editors

LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal
Departamento de Engenharia Química, Faculdade de Engenharia da Universidade do Porto, Rua Roberto Frias, 4200-465 Porto, Portugal
Dr. Jean Anne C. Incorvia
Department of Electrical and Computer Engineering, The University of Texas at Austin, Austin, TX 78712, USA

New Nanomaterials for Biomedical Applications

Abstract submission deadline
closed (30 October 2024)
Manuscript submission deadline
30 December 2024
Viewed by
1764

Topic Information

Dear Colleagues,

In recent years, nanomaterials have gained much interest in the biomedical field, namely in drug delivery, tissue engineering, phototherapy, magnetic hyperthermia therapy, immunotherapy, and antimicrobial therapy, among others. There is now a broad field of research on developing new nanomaterials specifically designed for the previously mentioned bio-applications. Features such as particle morphology (size, thickness, shape) and physicochemical properties play a crucial role in their biological effect and can be tuned to achieve the desired therapeutic outcomes. Surface chemistry and modifications, loading with drugs, or targeting molecules are often performed to maximize treatment efficacy and selectivity. In recent years, new nanomaterials have been introduced, such as graphene-based materials and other two-dimensional nanomaterials, which promise to revolutionize the field of nanomedicine. Nanomaterials produced by self-assembly also present high versatility and almost an illimited range of combinations and structures that can be explored.

This Topic invites original papers and reviews on the recent progress in the following areas:

  • Nanomaterials for biomedical applications, such as 2D nanomaterials; metallic-, polymeric-, and lipid-based nanoparticles; metallic-organic frameworks; and self-assembled nanoparticles.
  • Surface modification of nanomaterials, such as adsorption or chemical functionalization, to allow for the adjustment of the surface chemistry or for the loading of drugs. This includes functionalization with targeting molecules, antibodies, and/or immunotherapy agents.
  • Development of photo-responsive nanomaterials (for cancer phototherapy or antibacterial action) comprising an optimization of the properties and an understanding of the mechanisms that dictate their photothermal and/or photodynamic properties.
  • Study of drug loading and release from the surfaces of nanomaterials, their optimization, and biological effects.
  • New magnetic hyperthermia therapy agents (based on nanomaterials) with improved magnetic properties, stability in physiological media, biocompatibility, and therapeutic effects.
  • Study of nanomaterial-mediated immunomodulation to achieve an immunostimulatory effect (e.g., cancer therapy) or an immunosuppressive effect (e.g., autoimmune diseases).
  • Use of nanomaterials for tissue regeneration, cancer therapy, antibacterial effects, etc.—including the production of scaffolds and 3D-printed structures, among others—as well as for related applications as free-standing biomaterials (such as scaffolds, foams, films, etc.).

Articles combining different types of the above-mentioned therapies are highly welcome since this is still an unexplored subject in the field.

Dr. Artur M. Pinto
Dr. Fernão D. Magalhães
Dr. Jean Anne C. Incorvia
Topic Editors

Keywords

  • nanomaterials
  • two-dimensional nanomaterials
  • cancer therapy
  • drug delivery
  • phototherapy
  • magnetic hyperthermia therapy
  • tissue engineering
  • tissue regeneration
  • antimicrobial
  • antibacterial
  • immunotherapy

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Bioengineering
bioengineering
3.8 4.0 2014 15.6 Days CHF 2700 Submit
International Journal of Molecular Sciences
ijms
4.9 8.1 2000 18.1 Days CHF 2900 Submit
Nanomaterials
nanomaterials
4.4 8.5 2010 13.8 Days CHF 2900 Submit
Pharmaceutics
pharmaceutics
4.9 7.9 2009 14.9 Days CHF 2900 Submit
Scientia Pharmaceutica
scipharm
2.3 4.6 1930 31.4 Days CHF 1000 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (2 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
31 pages, 5629 KiB  
Review
CAR T Cell Nanosymbionts: Revealing the Boundless Potential of a New Dyad
by Juan C. Baena, Lucy M. Pérez, Alejandro Toro-Pedroza, Toshio Kitawaki and Alexandre Loukanov
Int. J. Mol. Sci. 2024, 25(23), 13157; https://doi.org/10.3390/ijms252313157 (registering DOI) - 7 Dec 2024
Viewed by 201
Abstract
Cancer treatment has traditionally focused on eliminating tumor cells but faces challenges such as resistance and toxicity. A promising direction involves targeting the tumor microenvironment using CAR T cell immunotherapy, which has shown potential for treating relapsed and refractory cancers but is limited [...] Read more.
Cancer treatment has traditionally focused on eliminating tumor cells but faces challenges such as resistance and toxicity. A promising direction involves targeting the tumor microenvironment using CAR T cell immunotherapy, which has shown potential for treating relapsed and refractory cancers but is limited by high costs, resistance, and toxicity, especially in solid tumors. The integration of nanotechnology into ICAM cell therapy, a concept we have named “CAR T nanosymbiosis”, offers new opportunities to overcome these challenges. Nanomaterials can enhance CAR T cell delivery, manufacturing, activity modulation, and targeting of the tumor microenvironment, providing better control and precision. This approach aims to improve the efficacy of CAR T cells against solid tumors, reduce associated toxicities, and ultimately enhance patient outcomes. Several studies have shown promising results, and developing this therapy further is essential for increasing its accessibility and effectiveness. Our “addition by subtraction model” synthesizes these multifaceted elements into a unified strategy to advance cancer treatment paradigms. Full article
(This article belongs to the Topic New Nanomaterials for Biomedical Applications)
Show Figures

Figure 1

24 pages, 18565 KiB  
Article
Injectable Photocrosslinked Hydrogel Dressing Encapsulating Quercetin-Loaded Zeolitic Imidazolate Framework-8 for Skin Wound Healing
by Zhao Chen, Man Zhe, Wenting Wu, Peiyun Yu, Yuzhen Xiao, Hao Liu, Ming Liu, Zhou Xiang and Fei Xing
Pharmaceutics 2024, 16(11), 1429; https://doi.org/10.3390/pharmaceutics16111429 - 10 Nov 2024
Viewed by 919
Abstract
Background: Wound management is a critical component of clinical practice. Promoting timely healing of wounds is essential for patient recovery. Traditional treatments have limited efficacy due to prolonged healing times, excessive inflammatory responses, and susceptibility to infection. Methods: In this research, [...] Read more.
Background: Wound management is a critical component of clinical practice. Promoting timely healing of wounds is essential for patient recovery. Traditional treatments have limited efficacy due to prolonged healing times, excessive inflammatory responses, and susceptibility to infection. Methods: In this research, we created an injectable hydrogel wound dressing formulated from gelatin methacryloyl (GelMA) that encapsulates quercetin-loaded zeolitic imidazolate framework-8 (Qu@ZIF-8) nanoparticles. Next, its ability to promote skin wound healing was validated through in vitro experiments and animal studies. Results: Research conducted both in vitro and in vivo indicated that this hydrogel dressing effectively mitigates inflammation, inhibits bacterial growth, and promotes angiogenesis and collagen synthesis, thus facilitating a safe and efficient healing process for wounds. Conclusions: This cutting-edge scaffold system provides a novel strategy for wound repair and demonstrates significant potential for clinical applications. Full article
(This article belongs to the Topic New Nanomaterials for Biomedical Applications)
Show Figures

Figure 1

Back to TopTop